CompareMarketResearchRequest a sample
Home / Healthcare / Artificial Pancreas Device

Healthcare · Market report

Artificial Pancreas Device Market Size, Share and Forecast 2026-2036

The global artificial pancreas device market is worth USD 6.2 bn in 2026 and is forecast to reach USD 20.0 bn by 2036, growing at a 12.5% CAGR. United States is the largest country market and Tubed pump systems is the largest by pump type segment.

USD 6.2 bnMarket size 2026
USD 20.0 bnForecast 2036
12.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global artificial pancreas device market is worth USD 6.2 bn in 2026 and is forecast to reach USD 20.0 bn by 2036, growing at a 12.5% CAGR. United States is the largest country market and Tubed pump systems is the largest by pump type segment.

ScopeAutomated insulin delivery systems that link an insulin pump, glucose sensor and control algorithm, including tubed and patch pumps and their consumables, sold to people with diabetes.
IndustryHealthcare
Value 2025USD 5.4 bn
Value 2026USD 6.2 bn
Value 2036USD 20.0 bn
CAGR 2026-203612.5%
Volume 20261,958 thousand users
Volume 20367,029 thousand users
Average price 2026USD 3,145 per user
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Artificial Pancreas Device market size and forecast, 2026-2036

Exhibit 1The global artificial pancreas device market is forecast to grow from USD 6.2 bn in 2026 to USD 20.0 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 12.5%
Artificial Pancreas Device market value, 2025 to 2036Market value by year. 2025: USD 5.4 bn; 2026: USD 6.2 bn; 2027: USD 6.9 bn; 2028: USD 7.8 bn; 2029: USD 8.8 bn; 2030: USD 9.9 bn; 2031: USD 11.1 bn; 2032: USD 12.5 bn; 2033: USD 14.0 bn; 2034: USD 15.8 bn; 2035: USD 17.8 bn; 2036: USD 20.0 bn. Compound annual growth rate 2026 to 2036: 12.5%.20256.2 bn202611.1 bn203120.0 bn203612.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 6.2 bn
2027USD 6.9 bn
2028USD 7.8 bn
2029USD 8.8 bn
2030USD 9.9 bn
2031USD 11.1 bn
2032USD 12.5 bn
2033USD 14.0 bn
2034USD 15.8 bn
2035USD 17.8 bn
2036USD 20.0 bn

Artificial Pancreas Device market segmentation

By pump type

Exhibit 2Tubed pump systems is the largest segment by pump type, with 46.0% of 2026 revenueEstimated share of 2026 global revenue, by pump type
Artificial Pancreas Device market share by pump type, 2026Share of 2026 revenue by pump type. Tubed pump systems: 46.0%; Patch pump systems: 46.0%; Other and open-source systems: 8.0%.Tubed pump systems46.0%Patch pump systems46.0%Other and open-source systems8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Tubed pump systems46.0%32.0%USD 2.8 bn8.5%
Patch pump systems46.0%60.0%USD 2.8 bn15.5%
Other and open-source systems8.0%8.0%USD 492 mn12.5%

By diabetes type

Exhibit 3Type 1 diabetes adds the most revenue by diabetes type, growing from USD 4.6 bn in 2026 to USD 11.5 bn by 2036Estimated revenue in USD by diabetes type, 2026 and 2036 forecast
Artificial Pancreas Device market by diabetes type, 2026 and 2036Revenue by diabetes type in 2026 and 2036. Type 1 diabetes: USD 4.6 bn in 2026, USD 11.5 bn in 2036, change +152%; Type 2 diabetes on insulin: USD 1.2 bn in 2026, USD 7.4 bn in 2036, change +501%; Other insulin-requiring diabetes: USD 369 mn in 2026, USD 1.1 bn in 2036, change +202%.20262036 forecastChangeType 1 diabetes+152%4.6 bn11.5 bnType 2 diabetes on insulin+501%1.2 bn7.4 bnOther insulin-requiring diabetes+202%369 mn1.1 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Type 1 diabetes74.0%57.4%USD 4.6 bn9.7%
Type 2 diabetes on insulin20.0%37.0%USD 1.2 bn19.6%
Other insulin-requiring diabetes6.0%5.6%USD 369 mn11.7%

By component

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Insulin pumps38.0%34.0%USD 2.3 bn11.3%
Continuous glucose monitors34.0%36.0%USD 2.1 bn13.1%
Control algorithm software16.0%19.0%USD 985 mn14.4%
Infusion sets and consumables12.0%11.0%USD 739 mn11.5%

By algorithm type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hybrid closed loop68.0%56.0%USD 4.2 bn10.3%
Advanced hybrid closed loop22.0%32.0%USD 1.4 bn16.8%
Predictive low glucose suspend10.0%12.0%USD 616 mn14.6%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Home users78.0%80.0%USD 4.8 bn12.8%
Hospitals and clinics16.0%14.0%USD 985 mn11.0%
Pediatric care centers6.0%6.0%USD 369 mn12.5%

Top 25 countries for artificial pancreas device by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.5% of 2026 revenue and the 25 countries below together hold 95.2%.

Exhibit 4United States is the largest country market at USD 3.2 bn in 2026, and the three largest countries hold 63.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Artificial Pancreas Device market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 3.2 bn, 52.0%; Germany: USD 369 mn, 6.0%; United Kingdom: USD 308 mn, 5.0%; France: USD 246 mn, 4.0%; Canada: USD 246 mn, 4.0%; Australia: USD 215 mn, 3.5%; Italy: USD 154 mn, 2.5%; Spain: USD 154 mn, 2.5%; Netherlands: USD 123 mn, 2.0%; Japan: USD 123 mn, 2.0%.United States3.2 bn 52.0%Germany369 mn 6.0%United Kingdom308 mn 5.0%France246 mn 4.0%Canada246 mn 4.0%Australia215 mn 3.5%Italy154 mn 2.5%Spain154 mn 2.5%Netherlands123 mn 2.0%Japan123 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 3.2 bn52.0%USD 10.6 bn12.7%
2GermanyUSD 369 mn6.0%USD 1.1 bn11.7%
3United KingdomUSD 308 mn5.0%USD 980 mn12.3%
4FranceUSD 246 mn4.0%USD 740 mn11.6%
5CanadaUSD 246 mn4.0%USD 780 mn12.2%
6AustraliaUSD 215 mn3.5%USD 720 mn12.8%
7ItalyUSD 154 mn2.5%USD 440 mn11.1%
8SpainUSD 154 mn2.5%USD 460 mn11.6%
9NetherlandsUSD 123 mn2.0%USD 400 mn12.5%
10JapanUSD 123 mn2.0%USD 360 mn11.3%
11South KoreaUSD 96 mn1.6%USD 348 mn13.7%
12IsraelUSD 81 mn1.3%USD 260 mn12.4%
13SwitzerlandUSD 78 mn1.3%USD 250 mn12.4%
14SwedenUSD 65 mn1.1%USD 210 mn12.4%
15BelgiumUSD 62 mn1.0%USD 200 mn12.4%
16AustriaUSD 59 mn1.0%USD 190 mn12.4%
17DenmarkUSD 52 mn0.8%USD 168 mn12.5%
18BrazilUSD 46 mn0.7%USD 166 mn13.8%
19MexicoUSD 34 mn0.6%USD 124 mn13.7%
20ChinaUSD 33 mn0.5%USD 106 mn12.5%
21IndiaUSD 26 mn0.4%USD 96 mn13.7%
22IrelandUSD 25 mn0.4%USD 82 mn12.5%
23PolandUSD 24 mn0.4%USD 88 mn13.9%
24Saudi ArabiaUSD 21 mn0.3%USD 76 mn13.8%
25TaiwanUSD 18 mn0.3%USD 68 mn13.9%
Rest of worldUSD 295 mn4.8%USD 948 mn12.4%
Exhibit 5United States and Germany account for 59% of the USD 13.8 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Artificial Pancreas Device market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 6.2 bn. United States: +USD 7.4 bn; Germany: +USD 750 mn; United Kingdom: +USD 672 mn; Canada: +USD 533 mn; Australia: +USD 504 mn; 20 other countries: +USD 3.3 bn; Rest of world: +USD 652 mn. Market value 2036: USD 20.0 bn.Market value 20266.2 bnUnited States+7.4 bnGermany+750 mnUnited Kingdom+672 mnCanada+533 mnAustralia+504 mn20 other countries+3.3 bnRest of world+652 mnMarket value 203620.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Medtronic
  • Insulet
  • Tandem Diabetes Care
  • Dexcom
  • Abbott

Group 2: Regional and specialist players

  • Ypsomed
  • Sequel Med Tech
  • CamDiab
  • Dana Diabetes Care
  • Roche Diabetes Care
  • Sooil Development
  • MicroTech Medical

Group 3: Emerging and niche players

  • Beta Bionics
  • Diabeloop
  • Medtrum
  • Inreda Diabetic

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the artificial pancreas device market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 12.5% is calculated from the resulting values.

The market is divided by pump type, by diabetes type, by component, by algorithm type, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the artificial pancreas device market?

The global artificial pancreas device market is estimated at USD 5.4 bn in 2025 and USD 6.2 bn in 2026.

How fast will the artificial pancreas device market grow?

It is forecast to reach USD 20.0 bn by 2036, a compound annual growth rate of 12.5% from 2026, an increase of USD 13.8 bn.

Which country is the largest market for artificial pancreas device?

United States is the largest market by revenue at USD 3.2 bn in 2026, 52.0% of the global total. The three largest countries together hold 63.0%.

Which country is growing fastest?

Among the ten largest markets, Australia is growing fastest at 12.8% a year from 2026 to 2036.

Which artificial pancreas device segment is largest?

In the by pump type split, Tubed pump systems is the largest segment with 46.0% of 2026 revenue.

Who are the leading artificial pancreas device companies?

Global leaders include Medtronic, Insulet, Tandem Diabetes Care, Dexcom.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Aquaculture Fungal Infection Treatment Ascites Fluid Removal Devices →

All Healthcare markets →

Request a sample